Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Asthma Burden in Mild Adult Asthma in the PEARL Survey: Asthma Control and Health Status.

The journal of allergy and clinical immunology. In practice·2026
Same author

Drivers of disparities in asthma exacerbation and healthcare utilization: a quantitative analysis of neighborhood deprivation in Southern California, United States.

Preventive medicine reports·2026
Same author

The Relationship Between Maternal Nonnarcotic Analgesics Allergy Labels and Maternal and Fetal Outcomes: Results From a Large Administrative Cohort.

The journal of allergy and clinical immunology. In practice·2026
Same author

Symptom patterns before and after indolent systemic mastocytosis: A matched cohort analysis.

The journal of allergy and clinical immunology. Global·2026
Same author

Cohort vs case-control design for transformer-based prediction of asthma exacerbations in mild asthma.

NPJ digital medicine·2026
Same author

Machine learning prediction of asthma and allergic rhinitis in children with early-onset atopic dermatitis.

The Journal of allergy and clinical immunology·2026

Related Experiment Video

Updated: Jun 2, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Improving asthma outcomes in large populations.

Michael Schatz1, Robert S Zeiger

  • 1Department of Allergy, Kaiser Permanente Medical Center, San Diego, CA 92111, USA. michael.x.schatz@kp.org

The Journal of Allergy and Clinical Immunology
|April 19, 2011
PubMed
Summary

Healthcare Effectiveness Data and Information Set (HEDIS) criteria for persistent asthma can effectively identify patients for asthma management. Using HEDIS data for persistent asthma can improve population management and quality of care assessments.

More Related Videos

Asthma Detection Research Based on Voice Signal Processing and Machine Learning
04:04

Asthma Detection Research Based on Voice Signal Processing and Machine Learning

Published on: July 22, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Related Experiment Videos

Last Updated: Jun 2, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Asthma Detection Research Based on Voice Signal Processing and Machine Learning
04:04

Asthma Detection Research Based on Voice Signal Processing and Machine Learning

Published on: July 22, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Area of Science:

  • Public Health
  • Health Services Research
  • Respiratory Medicine

Background:

  • Asthma management requires accurate identification of patient populations.
  • Existing methods for defining asthma severity, impairment, and risk vary.
  • Quality of care metrics are essential for improving patient outcomes.

Purpose of the Study:

  • To evaluate the utility of administrative and survey data for defining asthma control domains.
  • To assess the Healthcare Effectiveness Data and Information Set (HEDIS) definition of persistent asthma as a surrogate for survey-defined persistent asthma.
  • To identify reliable indicators for asthma population management and quality-of-care assessments.

Main Methods:

  • Utilized administrative data, mail/telephone surveys, and pharmacy dispensing records.
  • Defined asthma severity, impairment, and risk using validated tools and algorithms.
  • Calculated the asthma medication ratio (controllers vs. short-acting β-agonists) as a quality-of-care marker.

Main Results:

  • The 2-year HEDIS definition of persistent asthma is a strong surrogate for survey-defined persistent asthma.
  • Pharmacy data (SABA and oral corticosteroid dispensings, prior emergency care) effectively assess asthma risk.
  • The asthma medication ratio correlates with improved patient outcomes and is a recommended quality-of-care marker.

Conclusions:

  • HEDIS-defined persistent asthma is a reliable indicator for targeting asthma population management and quality assessments.
  • Leveraging administrative and pharmacy data offers efficient methods for assessing asthma control.
  • Outreach based on these indicators can improve asthma outcomes in diverse healthcare settings.